Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2022-04-04 17:11 Tx date 2022-04-01 |
$IMV
IMV Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+19,163 vol |
182,724 | |
Filed 2022-01-05 10:45 Tx date 2021-12-31 |
$IMV
IMV Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+22,702 vol |
163,561 | |
Filed 2021-10-01 13:34 Tx date 2021-09-30 |
$IMV
IMV Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+16,265 vol |
140,859 | |
Filed 2021-07-05 14:17 Tx date 2021-06-30 |
$IMV
IMV Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+13,841 vol |
124,594 | |
Filed 2021-04-01 13:41 Tx date 2021-03-31 |
$IMV
IMV Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+6,531 vol |
110,753 | |
Filed 2021-01-04 12:51 Tx date 2020-12-31 |
$IMV
IMV Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+5,734 vol |
104,222 | |
Filed 2020-10-05 10:51 Tx date 2020-09-30 |
$IMV
IMV Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+4,195 vol |
98,488 | |
Filed 2020-06-30 16:05 Tx date 2020-06-30 |
$IMV
IMV Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+6,302 vol |
94,293 | |
Filed 2020-04-02 10:08 Tx date 2020-03-31 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+11,503 vol |
87,991 | |
Filed 2020-01-03 10:09 Tx date 2019-12-31 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+6,579 vol |
76,488 | |
Filed 2019-10-04 08:46 Tx date 2019-10-03 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,600
+1,600 vol $3.50 each |
88,974 | |
Filed 2019-10-04 08:45 Tx date 2019-10-03 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$698.00
+200 vol $3.49 each |
87,374 | |
Filed 2019-10-04 08:44 Tx date 2019-10-03 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$348.00
+100 vol $3.48 each |
87,174 | |
Filed 2019-10-04 08:44 Tx date 2019-10-03 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,064
+600 vol $3.44 each |
87,074 | |
Filed 2019-10-02 14:12 Tx date 2019-09-30 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+6,556 vol |
69,909 | |
Filed 2019-07-03 09:00 Tx date 2019-06-30 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+6,466 vol |
63,353 | |
Filed 2019-06-21 11:01 Tx date 2019-06-21 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,250
+5,000 vol $4.25 each |
86,474 | |
Filed 2019-05-01 13:43 Tx date 2019-04-30 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,425
+2,500 vol $4.97 each |
81,474 | |
Filed 2019-04-18 11:43 Tx date 2019-04-17 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,250
+2,000 vol $4.63 each |
78,974 | |
Filed 2019-04-16 11:53 Tx date 2019-04-15 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,918
+4,600 vol $4.33 each |
76,974 | |
Filed 2019-04-03 07:37 Tx date 2019-03-31 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+4,783 vol |
56,887 | |
Filed 2019-01-03 Tx date 2018-12-31 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+4,069 vol |
52,104 | |
Filed 2018-12-17 Tx date 2018-12-17 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,125
+2,500 vol $7.25 each |
72,374 | |
Filed 2018-10-02 Tx date 2018-09-30 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+3,547 vol |
48,035 | |
Filed 2018-09-20 Tx date 2018-09-20 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,435
+500 vol $6.87 each |
66,074 | |
Filed 2018-09-20 Tx date 2018-09-20 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,275
+1,500 vol $6.85 each |
65,274 | |
Filed 2018-09-20 Tx date 2018-09-20 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,740
+400 vol $6.85 each |
69,874 | |
Filed 2018-09-20 Tx date 2018-09-20 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,384
+1,800 vol $6.88 each |
67,874 | |
Filed 2018-09-20 Tx date 2018-09-20 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$683.00
+100 vol $6.83 each |
63,374 | |
Filed 2018-09-20 Tx date 2018-09-20 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,728
+400 vol $6.82 each |
63,274 | |
Filed 2018-09-20 Tx date 2018-09-20 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,736
+400 vol $6.84 each |
63,774 | |
Filed 2018-09-20 Tx date 2018-09-20 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,058
+300 vol $6.86 each |
65,574 | |
Filed 2018-09-20 Tx date 2018-09-20 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,944
+1,600 vol $6.84 each |
69,474 | |
Filed 2018-07-05 Tx date 2018-06-30 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+2,981 vol |
44,488 | |
Filed 2018-06-08 Tx date 2018-06-08 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,965
+3,500 vol $7.99 each |
62,874 | |
Filed 2018-06-05 Tx date 2018-06-05 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,200
+2,400 vol $8.00 each |
59,374 | |
Filed 2018-06-05 Tx date 2018-06-05 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$799.00
+100 vol $7.99 each |
56,974 | |
Filed 2018-05-24 Tx date 2018-05-02 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-6,875 vol |
3,125 | |
Filed 2018-05-24 Tx date 2018-05-02 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-125,126 vol |
56,874 | |
Filed 2018-05-24 Tx date 2018-05-02 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-20,625 vol |
9,375 | |
Filed 2018-05-24 Tx date 2018-05-02 |
$IMV
IMV Inc. (formerly Immunovaccine Inc.) |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
37 - Stock split or consolidation
|
-91,316 vol |
41,507 | |
Filed 2018-04-04 Tx date 2018-03-31 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+8,333 vol |
132,823 | |
Filed 2018-03-22 Tx date 2018-03-22 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$990.00
+500 vol $1.98 each |
172,500 | |
Filed 2018-03-22 Tx date 2018-03-22 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,905
+9,500 vol $1.99 each |
182,000 | |
Filed 2018-01-10 Tx date 2018-01-09 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,250
+5,000 vol $2.25 each |
167,000 | |
Filed 2018-01-10 Tx date 2018-01-10 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,100
+5,000 vol $2.22 each |
172,000 | |
Filed 2018-01-04 Tx date 2017-12-31 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$16,249
+7,065 vol $2.30 each |
124,490 | |
Filed 2017-10-03 Tx date 2017-09-30 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$16,250
+14,640 vol $1.11 each |
117,425 | |
Filed 2017-07-05 Tx date 2017-06-30 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$16,249
+14,130 vol $1.15 each |
102,785 | |
Filed 2017-06-22 Tx date 2016-04-14 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-06-22 Tx date 2017-06-21 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$13,000
+10,000 vol $1.30 each |
10,000 | |
Filed 2017-06-22 Tx date 2016-04-14 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-06-22 Tx date 2017-06-21 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$39,000
+30,000 vol $1.30 each |
30,000 | |
Filed 2017-04-25 Tx date 2017-04-24 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-25,000 vol |
0 | |
Filed 2017-04-25 Tx date 2017-04-24 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$18,000
+25,000 vol $0.72 each |
137,000 | |
Filed 2017-04-25 Tx date 2017-04-25 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$31,250
+25,000 vol $1.25 each |
162,000 | |
Filed 2017-04-04 Tx date 2017-03-31 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$16,249
+13,655 vol $1.19 each |
88,655 | |
Filed 2016-12-23 Tx date 2016-04-14 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-12-23 Tx date 2016-12-21 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$54,000
+75,000 vol $0.72 each |
75,000 | |
Filed 2016-12-12 Tx date 2016-12-09 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$20,250
+27,000 vol $0.75 each |
112,000 | |
Filed 2016-11-17 Tx date 2016-11-17 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,500
+25,000 vol $0.78 each |
85,000 | |
Filed 2016-07-04 Tx date 2016-07-04 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,300
+10,000 vol $0.63 each |
60,000 | |
Filed 2016-06-09 Tx date 2016-06-08 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+25,000 vol |
25,000 | |
Filed 2016-06-09 Tx date 2016-04-14 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-06-09 Tx date 2016-06-08 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$27,500
+50,000 vol $0.55 each |
50,000 | |
Filed 2016-06-09 Tx date 2016-06-08 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$27,500
+50,000 vol $0.55 each |
||
Filed 2016-06-08 Tx date 2016-06-08 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$27,500
+50,000 vol $0.55 each |
50,000 | |
Filed 2016-06-08 Tx date 2016-04-14 |
$IMV
Immunovaccine Inc. |
Sheldon, Andrew J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|